EPIS® Právní systém | Plné znění

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2021/849

xx xxx 11.&xxxx;xxxxxx 2021,

xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxx xxxx část 3 xxxxxxx XX xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx a směsí

(Text x&xxxx;xxxxxxxx xxx EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxxxxx Xxxxxxxx unie,

s ohledem xx xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) č. 1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, o změně x&xxxx;xxxxxxx xxxxxxx 67/548/EHS x&xxxx;1999/45/XX a o změně xxxxxxxx (XX) x.&xxxx;1907/2006&xxxx;(1), x&xxxx;xxxxxxx xx čl. 37 odst. 5 xxxxxxxxx xxxxxxxx,

xxxxxxxx k těmto xxxxxxx:

(1)	Xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx XX xxxxxxxx (XX) x.&xxxx;1272/2008 xxxxxxxx seznam xxxxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxxxxx xxxxx na xxxxxxx xxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxx 2 xx 5 xxxxxxx X&xxxx;xxxxxxxxx xxxxxxxx.

(2)

Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx (xxxx xxx „xxxxxxxx“) xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxx&xxxx;37 xxxxxxxx (XX) x.&xxxx;1272/2008 předloženy xxxxxx xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxx a označení xxxxxxxxx xxxxx x&xxxx;xx xxxxxxxxxxx xxxx xxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxx některých xxxxxx xxxxx. Xxxx, xx Výbor pro xxxxxxxxxx xxxxx (RAC) xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxxx stran, xxxxxx x&xxxx;xxxxx xxxxxxx xxxxxxxxxx&xxxx;(2). Xxxxxxx xxxxxxxxxx xxxxxx XXX jsou:

—	stanovisko ze xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx 1,2,4-xxxxxxx,

—	xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 xxx 1,4-xxxxxx,

—	xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 xxx benzyl-salicylát,

—	stanovisko xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxx (XXX),

—	xxxxxxxxxx xx xxx 15. března 2019 xxx xxxxxxxx (ISO),

—	stanovisko xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxxxx xxxxxxx xxx xxxxxxxxxxx xxxxxxxxxxxx pro xxxxx prostředí u látek xxxxxxxxxxxx xxx uvedených x&xxxx;xxxxxxxx Xxxxxx (XX) 2016/1179,

—	xxxxxxxxxx xx dne 15.&xxxx;xxxxxx&xxxx;2019 xxx X-{2-[[1,1’-xx(xxxxxxxxxxx)]-2-xx]xxxxx}-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxx,

—	xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx N-methoxy-N-[1-methyl-2-(2,4,6-trichlorfenyl)ethyl]-3-(difluormethyl)-1-methylpyrazol-4-karboxamid; xxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx p-cymen; 1-xxxxxxxxx-4-xxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx x-xxxxxx-1,3-xxxx; α-xxxxxxxx; 1-isopropyl-4-methylcyklohexa-1,3-dien,

—	stanovisko xx xxx 15.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx (R)-p-mentha-1,8-dien, x-xxxxxxx,

—	xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxx-xxxxxx,

—	xxxxxxxxxx xx xxx 15. března 2019 xxx xxxxxxxxx-xxxxxx (XXX), X-(2,6-xxxxxxx-x-xxxxx) X,X-xxxxxxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 15.&xxxx;xxxxxx&xxxx;2019 pro xxxxxxxxxx,

—	xxxxxxxxxx xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxx xxxxxxxx,

—	xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxx,

—	xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx 2-fenoxyethan-1-ol,

—	stanovisko xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx 2,2-xxxxxx-2-xxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx 3-xxxxxxxxxxx-3,5,5-xxxxxxxxxxxxxxxxxxx-1-xxxx,

—	xxxxxxxxxx xx xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx 6,6’-xx-xxxx-xxxxx-2,2’-xxxxxxxxxx-x-xxxxxx;

—	xxxxxxxxxx ze xxx 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxxxx (ISO), X-(2,4-xxxxxxxxxxxx)-2-[3-(xxxxxxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx;

—	xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx imidakloprid (XXX), 1-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-X-xxxxxxxxxxxxxxxxx-2-xxxxxxxxxx,

—	xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx xxxxxxxxxx,

—	xxxxxxxxxx xx dne 13.&xxxx;xxxxxx&xxxx;2019 xxx X-xxxxxxxxxx xxxxxxxx,

—	xxxxxxxxxx xx xxx 13. června 2019 xxx xxxxxxxx(2,6-xxxxxxxxxxxxx)-x-xxxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx 1,2-xxxxx-4-xxxxxxxxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 20.&xxxx;xxxx&xxxx;2019 xxx 4-xxxxxxxxxxxx-2-xx,

—	xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx xxxxxxx; xxxx xxxxxx; xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx; xxxxxxxxxxxx xxxxxxx, bezvodý; xxxxxx xxx xxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxx xxxxxxx, xxxxxxxxxx; xxxxxxxxxxxx xxxxxxx, pentahydrát,

—	stanovisko xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx xxxxxxxxxx,

—	xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx,

—	xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxx,

—	xxxxxxxxxx xx dne 20.&xxxx;xxxx&xxxx;2019 xxx dimethomorf,

—	stanovisko xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxx xxxxxxx,

—	xxxxxxxxxx xx xxx 20. září 2019 xxx xxxxxxxxxxxx (ISO); [(X)-(3-xxxxxxxxxxx)xxxxxxxxxx]-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxxxxxxxxx-xxxxxx (XXX),

—	xxxxxxxxxx ze xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxxxx-X (XXX); (X)-2-(4-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxx xxxxxxxx x&xxxx;xxxx xxxx,

—	xxxxxxxxxx ze xxx 20.&xxxx;xxxx&xxxx;2019 xxx xxxxxx-xxxxxxxxx,

—	xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 xxx fenmedifam (XXX),

—	xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 pro trifloxystrobin (XXX),

—	xxxxxxxxxx xx xxx 20.&xxxx;xxxx&xxxx;2019 pro xxxxxxxxxxxx,

—	xxxxxxxxxx xx dne 5.&xxxx;xxxxxxxx&xxxx;2019 xxx 1,4-dimethylnaftalen,

—	stanovisko xx xxx 5. prosince 2019 pro 3xX,5X,6X,7xX,7xX,9xX,10X,12xX,12xX)-10-[(2X,3X,4X,5X)-3,4-xxxxxxxxx-5,6-xxxxxxxxxxxxxx-2-xx]-5,6-xxxxxxxxx-7x,9x-xxxxxxxxxxxxxxxxxxxxx-3X-xxxxx[x]xxxxxx[5,4-x]xxxxxx-3-xx; 24-xxxxxxxxxxxxxx,

—	xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 pro 3-xxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxxx (XXX); methyl-N- (xxxxxxxxxxxx-2-xx)xxxxxxxx,

—	xxxxxxxxxx xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxxxx xxx/xxxxx +/- 40/60; (XX)-α-xxxx-3-xxxxxxxxxxxx (1XX,3XX;1XX,3XX)-3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxx,

—	xxxxxxxxxx xx dne 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxx (XXX); (XX)-2-(4-xxxxxxxxx-4-xxxxxx-5-xxx-4,5-xxxxxxxxxxxxxxx-2-xx)-5-(xxxxxxxxxxxxx)xxxxxxxxxxx kyselinu,

—	stanovisko xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxxxxxxxxx,

—	xxxxxxxxxx ze xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx xxxxxxxxxxxx (XXX); N-nitro-{3-[(2-chlorthiazol-5-yl)methyl]-5-methyl-1,3,5-oxadiazinan-4-yliden}amin,

—	stanovisko xx xxx 5.&xxxx;xxxxxxxx&xxxx;2019 xxx trinexapak-ethyl (XXX); xxxxx-4-[xxxxxxxxxxx(xxxxxxx)xxxxxxxx]-3,5-xxxxxxxxxxxxxxxxxxxxxxxxx.

(3)

Xxxxxx akutní toxicity (XXX) se xxxxxxxxx xxxxxxx xx xxxxxxxxx xxxxxxxxxxx akutní xxxxxxxx x&xxxx;xxxxxxxx lidského xxxxxx x&xxxx;xxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxx xxxxx xxxxxxxxxx xxxxxx xxxxxxxx. Xxxxxxxxx harmonizovaných xxxxxx XXX do xxxxxxx xxxxxxxxx x&xxxx;xxxxxxx XX xxxxxxxx (ES) č. 1272/2008 xxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxx a poskytuje xxxxxxx xxxxxxx xxxxxxxxx prosazováním. Xx xxxxxxx xxxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxx agentura xxxxxxxxx xxxxxxx XXX xxx xxxx xxxxx, xxxxxxx-xxxxxxxxxxx xxxxxxxxx, hexahydroxid-síran xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx xxxxxx, xxxxxx xxxxxx (xxxxxxxx xxxxxxxxxxx kyselinou), xxxxxxxxx xxxxxxx – hydroxid xxxxxxx (1:1) x&xxxx;xxxxxxxx xxxxxxx; xxxxxxxx xxxxxxx, xxxxxxxxxxxx xxxxx; xxxxxxx xxxxxxxx xxxxxx xxxxxxxxx x&xxxx;xxxxxxxxx vápenatého a síran xxxxxxx, xxxxxxxxxxx, kromě xxxxxxxx xxxxxxxxxxxx ve xxxxxxxxxxxx výboru RAC xxx jiné látky. Xxxxxxx hodnoty ATE xx měly být xxxxxxxx xx předposledního xxxxxxx xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx XX xxxxxxxx (ES) x.&xxxx;1272/2008.

(4)

Xxxxxx obdržela xxxxxxxxx xxxxxxxxx, xxxxx zpochybnily xxxxxxx xxxxxxxxx uvedené xx xxxxxxxxxxxx XXX xx xxx 15.&xxxx;xxxxxx&xxxx;2019 xxxxxxxxxx xx xxxxxxxxx, xx xxx 20.&xxxx;xxxx&xxxx;2019 xxxxxxxx xx 4-xxxxxx-2-xxxxxxxxx x&xxxx;xx xxx 20.&xxxx;xxxx&xxxx;2019 xxxxxxxx se xxxxxxxxxxxx. Xxxxxx xxxx xxxxxxxxx xxxxxxxxx a neshledala je xx dostatečné x&xxxx;xxxx, xxx zpochybnily vědeckou xxxxxxx obsaženou ve xxxxxxxxxxxx XXX.

(5)	Xxxxxx xxxxx xxxxxxxx xx vhodné xxxxxx, xxxxxxxxxxxx či xxxxxx harmonizovanou xxxxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxx xxxxx.

(6)	Xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(7)

Xxxxxxxxxx xxxxxx xxxx xxxxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx by xxxxxx xxx, x&xxxx;xxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx požadavků, xxxxxxxxxx xxxxx, xxxxxxx xxxxxxxxxx xxxxxxxxx určitou xxxx xx xx, xxx přizpůsobili xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx xxxxx xxxx xxxxxxxxxxx xxxxxxxxxxxx a prodali stávající xxxxxx. Xxxx xxxx xx xxxxxx xxxxxxxx x&xxxx;xxxx, xxx dodavatelé xxxx dostatek xxxx xxxxxxxx opatření xxxxx x&xxxx;xxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxx právních xxxxxxxxx, xxxxx vznikají x&xxxx;xxxxxxxx xxxx provedených xxxxx xxxxxx xxxxxxxx. Xxxx xxxxxxxxx xxxxx xxxxxxxxx xxxxxxxxx stanovené x&xxxx;xx.&xxxx;22 xxxx.&xxxx;1 písm. f) xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1907/2006&xxxx;(3) xxxx xxxxxxxxx stanovené x&xxxx;xxxxxx&xxxx;50 xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;528/2012&xxxx;(4). Dodavatelům xx xxxx mělo xxx xxxxxxxx používat nové xxxx xxxxxxxxxxxxx harmonizované xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxx způsobem xxxxxxxxxxx označování x&xxxx;xxxxxx xx dobrovolném základě xxxx xxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxx a ode xxx xxxx xxxxxx x&xxxx;xxxxxxxx, xxx byla xxxxxxxxx xxxxxx úroveň xxxxxxx xxxxxxxx xxxxxx x&xxxx;xxxxxxxxx prostředí x&xxxx;xxx xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Xxxxxxx 3 x&xxxx;xxxxx 3 xxxxxxx XX xxxxxxxx (ES) x.&xxxx;1272/2008 xx xxxx x&xxxx;xxxxxxx x&xxxx;xxxxxxxx tohoto nařízení.

Článek 2

Vstup x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxx

Xxxx xxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx xxxx po xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxxxxx xx xxx xxx 17.&xxxx;xxxxxxxx 2022.

Xxxxxxxx xx druhého xxxxxxxxxxx xxxxxx článku xxxxx xxx xxxxx x&xxxx;xxxxx xxxxxxxxxxxxx, označovány x&xxxx;xxxxxx v souladu x&xxxx;xxxxx xxxxxxxxx xxx xxx xxxx xxxxxx x&xxxx;xxxxxxxx.

Xxxx xxxxxxxx xx xxxxxxx x&xxxx;xxxxx xxxxxxx x&xxxx;xxxxx xxxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxx.

X&xxxx;Xxxxxxx xxx 11.&xxxx;xxxxxx 2021.

Xx Xxxxxx

xxxxxxxxxxx

Xxxxxx XXX XXX XXXXX

(1)&xxxx;&xxxx;Xx. věst. X&xxxx;353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxxxx xxxx xxxxxxxx xx xxxx xxxxxxxxxxx stránce: xxxxx://xxxx.xxxxxx.xx/xxxxxxxx-xx-xxx-xxxxxxxxxx-xxxxx-xxxxxxx/-/xxxxxxx/xxxx/-/xxXxxxxx/-/xxxXxxxxx/-/xxx_xxxxxxxXxxx/-/xxx_xxxxxxxXx/-/xxx_xxxxxx_xxxxxx/Xxxxxxx+Xxxxxxx/xxx_xxxxxxxxxXxxx/-/xxx_xxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxxxxXxxx/-/xxx_xxxxxxxx_xxxxxxxxXx/-/xxx_xxxxxxxx_xxxxxx/-/xxx_xxxxxxxxx/-/xxx_xxxxxxxxxxXxxx/-/xxx_xxxxxxxxxxXx/-/xxx_xxxxxxxxxx_xxxxxxxxx/-/

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;1907/2006 ze xxx 18. prosince 2006o registraci, xxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx xxxxx, x&xxxx;xxxxxxx Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/XX x&xxxx;x&xxxx;xxxxxxx nařízení Xxxx (EHS) x.&xxxx;793/93, xxxxxxxx Xxxxxx (XX) x.&xxxx;1488/94, xxxxxxxx Rady 76/769/XXX x&xxxx;xxxxxxx Komise 91/155/XXX, 93/67/EHS, 93/105/ES x&xxxx;2000/21/XX (Úř. xxxx. X&xxxx;396, 30.12.2006, x.&xxxx;1).

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Rady (XX) x.&xxxx;528/2012 xx xxx 22.&xxxx;xxxxxx&xxxx;2012x&xxxx;xxxxxxxx xxxxxxxxxx xxxxxxxxx xx xxx x&xxxx;xxxxxx používání(Úř. xxxx. X&xxxx;167, 27.6.2012, s. 1).

PŘÍLOHA

V příloze XX nařízení (XX) č. 1272/2008 se xxxxxxx 3 v části 3 xxxx xxxxx:

Xxxxxxxx xx tyto xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE	Poznámky
Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Kódy xxxx x&xxxx;xxxxxxxxx nebezpečnosti	Kódy xxxxxxxxxxxx xxx o nebezpečnosti	Kódy xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx a ATE	Poznámky
„601-093-00-6	1,4-xxxxxxxxxxxxxxxx	209-335-9	571-58-4	Xxxxx Tox. 4 Xxx. Xxx. 1 Xxx Xxxxx. 2 Xxxxxxx Acute 1 Xxxxxxx Chronic 3	H302 H304 H319 H400 H412	GHS07 GHS08 GHS09 Dgr	H302 H304 H319 H410		orální: XXX&xxxx;= 1&xxxx;300 &xxxx;xx/xx XX X&xxxx;= 1“
„601-094-00-1	1-xxxxxxxxx-4-xxxxxxxxxxxx; x-xxxxx	202-796-7	99-87-6	Xxxx. Liq. 3 Xxxxx Xxx. 3 Xxx. Xxx. 1 Xxxxxxx Xxxxxxx 2	X226 X331 X304 X411	XXX02 XXX06 XXX08 XXX09 Xxx	X226 X331 X304 X411		xxxxxxxxx: XXX&xxxx;= 3&xxxx;xx/x (xxxx)“
„601-095-00-7	x-xxxxxx-1,3-xxxx; 1-isopropyl-4-methylcyklohexa-1,3-dien α-terpinen	202-795-1	99-86-5	Flam. Xxx. 3 Xxxxx Xxx. 4 Xxxx Xxxx. 1 Asp. Xxx. 1 Xxxxxxx Xxxxxxx 2	H226 H302 H317 H304 H411	GHS02 GHS07 GHS08 GHS09 Dgr	H226 H302 H317 H304 H411		orální: XXX&xxxx;= 1 680 &xxxx;xx/xx XX“
„602-110-00-X	xxxxxxxxxxxxxxxxx	204-126-9	116-14-3	Xxxx. 1X	X350	XXX08 Xxx	X350“
„604-095-00-5	6,6’-xx-xxxx-xxxxx-2,2’-xxxxxxxxxx-x-xxxxxx; [XXXX]	204-327-1	119-47-1	Xxxx. 1X	X360X	XXX08 Xxx	X360X“
„606-152-00-X	(5-xxxxx-2-xxxxxxx-4-xxxxxx-3-xxxxxxx)(4,5,6-xxxxxxxxxx-x-xxxxx)xxxxxxxx; xxxxxxxxxx	-	688046-61-9	Xxxx. 2 Xxxxxxx Chronic 1	X351 X410	XXX08 XXX09 Xxx	X351 X410		X&xxxx;= 1“
„607-747-00-7	2,2-dibrom-2-kyanoacetamid; [XXXXX]	233-539-7	10222-01-2	Xxxxx Xxx. 2 Xxxxx Xxx. 3 XXXX XX 1 Xxxx Xxxxx. 2 Xxx Xxx. 1 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X330 X301 X372 (xxxxxxx xxxxx) (xxxxxxxxx) X315 X318 X317 X400 X410	XXX06 XXX08 XXX05 XXX09 Xxx	X330 X301 X372 (xxxxxxx xxxxx) (xxxxxxxxx) X315 X318 X317 X410		xxxxxxxxx: ATE = 0,24 mg/l (xxxxx xxxx xxxx) xxxxxx: XXX&xxxx;= 118 mg/kg XX X&xxxx;= 1 X&xxxx;= 1“
„607-748-00-2	[X-(X,X)]-5-(-1-xxxxxxx-2,6,6-xxxxxxxxx-4-xxxxxxxxxxx-2-xx-1-xx)-3-xxxxxxxxxxx-2,4-xxxxxxx xxxxxxxx; X-xxxxxxxxx xxxxxxxx	244-319-5	21293-29-8	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H400 H410	GHS09 Wng	H410		M = 1 X&xxxx;= 1“
„607-749-00-8	xxxxxx-xxxxxxxxx	204-317-7	119-36-8	Xxxx. 2 Acute Tox. 4 Xxxx Xxxx. 1X Xxxxxxx Xxxxxxx 3	H361d H302 H317 H412	GHS07 GHS08 Wng	H361d H302 H317 H412		orální: ATE = 890&xxxx;xx/xx XX“
„607-750-00-3	xxxxxxxxx xxxxxxxx	201-069-1	77-92-9	Xxx Xxxxx. 2 STOT SE 3	X319 X335	XXX07 Xxx	X319 X335“
„607-751-00-9	xxxxxxxxxxxxxxx-xxxxxx (XXX); xxxxxx-2-({[4-xxxxxx-6-(xxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxx}xxxxxxxxx)xxxxxxx	-	97780-06-8	Xxx Xxxxx. 2 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X319 X400 X410	XXX07 XXX09 Xxx	X319 X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„607-752-00-4	xxxxxxxxxx-xxxxx (XXX); xxxxx-4-[xxxxxxxxxxx(xxxxxxx)xxxxxxxx]-3,5-xxxxxxxxxxxxxxxxxxxxxxxxx	-	95266-40-3	XXXX RE 2 Xxxx Sens. 1B Aquatic Xxxxxxx 1	H373 (xxxxxxxxxxxxxxxxxx xxxxx) X317 X410	XXX08 XXX07 XXX09 Xxx	X373 (xxxxxxxxxxxxxxxxxx xxxxx) X317 X410		X&xxxx;= 1“
„607-753-00-X	(3xX,5X,6X,7xX,7xX,9xX,10X,12xX,12xX)-10-[(2X,3X,4X,5X)-3,4-xxxxxxxxx-5,6-xxxxxxxxxxxxxx-2-xx]-5,6-xxxxxxxxx-7x,9x-xxxxxxxxxxxxxxxxxxxxx-3X-xxxxx[x]xxxxxx[5,4-x]xxxxxx-3-xx; 24-xxxxxxxxxxxxxx	-	78821-43-9	Xxxxxxx Xxxxxxx 4	X413		X413“
„607-754-00-5	xxxxxx-xxxxxxxxx	204-262-9	118-58-1	Xxxx Xxxx. 1X	X317	XXX07 Xxx	X317“
„607-755-00-0	(XX)-1-{1-xxxxx-4-[4-xxxxx-3-(2-xxxxxxxxxxxxx)-x-xxxxxxx]xxxxxxx-5-xxxxx}xxxxx-xxxxxx-xxxxxxxx; xxxxxxxxxx	-	1101132-67-5	Xxxx. 2 Xxxx. 2 STOT XX 2 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X351 X361xx X373 (oči) H400 H410	GHS08 GHS09 Wng	H351 H361fd H373 (xxx) X410		X&xxxx;= 10 X&xxxx;= 100“
„613-337-00-9	xxxxxxxxxxxxxx (XXX); 2-[2-(1-xxxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxx)-2-xxxxxxxxxxxxx]-2,4-xxxxxxx-3X-1,2,4-xxxxxxx-3-xxxxx	-	178928-70-6	Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 10 X&xxxx;= 1“
„613-338-00-4	xxxxxxxxxxx (XXX); S-[(6-chlor-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl]-(O,O-dimethyl)thiofosfát	252-626-0	35575-96-3	Carc. 2 Xxxxx Xxx. 3 Acute Xxx. 4 XXXX XX 1 Xxxx Xxxx. 1 Aquatic Xxxxx 1 Xxxxxxx Chronic 1	X351 X331 X302 X370 (xxxxxxx xxxxxx) X317 X400 X410	XXX06 XXX08 XXX09 Xxx	X351 X331 X302 X370 (xxxxxxx xxxxxx) X317 X410		xxxxxxxxx: XXX&xxxx;= 0,5&xxxx;xx/x (xxxxx nebo xxxx) xxxxxx: ATE = 500 mg/kg XX X&xxxx;= 1&xxxx;000 X&xxxx;= 1 000 “
„613-339-00-X	3-xxxxxxxxxxxxx	215-925-7	1453-58-3	Xxxx. 1X Xxxxx Xxx. 4 XXXX XX 2 Xxxx Xxxx. 1 Eye Dam. 1	X360X X302 X373 (xxxxx) X314 X318	XXX08 XXX07 XXX05 Xxx	X360X X302 X373 (plíce) H314		orální: XXX&xxxx;= 500&xxxx;xx/xx XX“
„613-340-00-5	xxxxxxxx (XXX); 2-(2-xxxxxxxxxxx)-4,4-xxxxxxxx-1,2-xxxxxxxxxx-3-xx	-	81777-89-1	Xxxxx Xxx. 4 Xxxxx Tox. 4 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X332 X302 X400 X410	XXX07 XXX09 Xxx	X332 X302 X410		xxxxxxxxx: ATE = 4,85&xxxx;xx/x (xxxxx nebo xxxx) xxxxxx: XXX&xxxx;= 768 mg/kg TH M = 1 X&xxxx;= 1“
„614-030-00-2	xxxxxxxxx-xxxxxxx (ISO); (4“X)-4“-xxxxx-4“-(xxxxxxxxxxx)xxxxxxxxxx X1-xxxxxxx	-	155569-91-8	Xxxxx Xxx. 3 Xxxxx Xxx. 3 Xxxxx Xxx. 3 XXXX XX 1 XXXX XX 1 Eye Xxx. 1 Aquatic Acute 1 Xxxxxxx Chronic 1	X331 X311 X301 X370 (xxxxxxx xxxxxx) X372 (nervový xxxxxx) X318 X400 X410	XXX06 XXX05 XXX08 XXX09 Xxx	X331 X311 X301 X370 (nervový xxxxxx) X372 (xxxxxxx xxxxxx) X318 X410		xxxxxxxxx: XXX&xxxx;= 0,663 xx/x (xxxxx nebo mlha) dermální: ATE = 300 xx/xx XX xxxxxx: XXX = 60&xxxx;xx/xx XX XXXX RE 1; X372: X&xxxx;≥&xxxx;5&xxxx;%; XXXX XX 2; X373: 0,5&xxxx;% ≤ X&xxxx;&xx;&xxxx;5&xxxx;% X&xxxx;= 10&xxxx;000 X&xxxx;= 10&xxxx;000 “
„616-234-00-7	X-xxxxxxx-X-[1-xxxxxx-2-(2,4,6-xxxxxxxxxxxxx)-xxxxx]-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxxx-4-xxxxxxxxxx; xxxxxxxxxxxxxx	-	1228284-64-7	Xxxx. 2 Xxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X361x X400 X410	XXX08 XXX09 Xxx	X351 X361x X410		X&xxxx;= 1 X&xxxx;= 1“
„616-235-00-2	X-{2-[[1,1’-xx(xxxxxxxxxxx)]-2-xx]xxxxx}-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx; xxxxxxx	-	874967-67-6	Xxxx. 2 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 2	X351 X400 X411	XXX08 XXX09 Xxx	X351 X410		X&xxxx;= 1“

xxxxxxx xxxxxxxxxxxx xxxxxxxxx číslům 005-007-00-2; 005-008-00-8; 005-011-00-4; 005-011-01-1; 005-011-02-9; 006-069-00-3; 006-076-00-1; 015-113-00-0; 028-007-00-4; 029-002-00-X; 029-015-00-0; 029-016-00-6; 029-017-00-1; 029-018-00-7; 029-019-01-X; 029-020-00-8; 029-021-00-3; 029-022-00-9; 029-023-00-4; 601-029-00-7; 601-096-00-2; 603-024-00-5; 603-066-00-4; 603-098-00-9; 606-004-00-4; 607-421-00-4; 607-424-00-0; 607-434-00-5; 608-058-00-4; 612-067-00-9; 612-252-00-4; 613-048-00-8; 613-102-00-0; 613-111-00-X; 613-166-00-X; 613-208-00-7; 613-267-00-9; 613-282-00-0; 616-032-00-9; 616-106-00-0 x&xxxx;616-113-00-9 xx nahrazují xxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx x&xxxx;XXX	Xxxxxxxx
Xxxxxxxx xxxxx	Xxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx výstražných xxxxxxx a signálních xxxx	Xxxx xxxxxxxxxxxx xxx o nebezpečnosti	Kódy xxxxx. standardních vět x&xxxx;xxxxxxxxxxxxx		Xxxxxxxx
„005-007-00-2	xxxxxxxx xxxxxx [1] kyselina xxxxxx [2]	233-139-2 [1] 234-343-4 [2]	10043-35-3 [1] 11113-50-1 [2]	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„005-008-00-8	xxxx xxxxxx	215-125-8	1303-86-2	Xxxx. 1B	H360FD	GHS08 Dgr	H360FD“
„005-011-00-4	tetraboritan xxxxxxx, xxxxxxxxxx; [1] tetraboritan xxxxxxx, xxxxxxx; [2] sodná xxx kyseliny xxxxxxxxxxx [3] xxxxxxxxxxxx disodný, dekahydrát [4] xxxxxxxxxxxx disodný xxxxxxxxxxx [5]	235-541-3 [1] 215-540-4 [2] 237-560-2 [3] 215-540-4 [4] 215-540-4 [5]	12267-73-1 [1] 1330-43-4 [2] 13840-56-7 [3] 1303-96-4 [4] 12179-04-3 [5]	Xxxx. 1B	H360FD	GHS08 Dgr	H360FD“


„006-069-00-3	thiofanát-methyl (XXX); xxxxxxxx (1,2-fenylendikarbamothioyl)dikarbamát; dimethyl 4,4′-(x-xxxxxxx)xxx(3-xxxxxxxxxxxxx)	245-740-7	23564-05-8	Xxxx. 2 Xxxx. 2 Xxxxx Xxx. 4 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X351 X341 X332 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X341 X332 X317 X410		xxxxxxxxx: XXX&xxxx;= 1,7&xxxx;xx/x (xxxxx xxxx mlha) M = 10 X&xxxx;= 10“
„006-076-00-1	xxxxxxxx (XXX); N,N’-ethylenbis(dithiokarbamát) xxxxxxxxx, xxxxxxxxx xxxxxxx xx xxxxxxxxxx xxxx	-	8018-01-7	Xxxx. 2 Xxxx. 1X XXXX RE 2 Xxxx Sens. 1 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X360X X373 (xxxxxx xxxxx, xxxxxxx xxxxxx) X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X360X X373 (xxxxxx xxxxx, xxxxxxx systém) H317 H410		M = 10 X&xxxx;= 10“
„015-113-00-0	xxxxxxxxx-xxxxxx (ISO); O-(2,6-dichlor-p-tolyl) X,X-xxxxxxxxxxxxxxxxxx	260-515-3	57018-04-9	Xxxx Xxxx. 1B Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X317 X400 X410	XXX07 XXX09 Xxx	X317 X410		X&xxxx;= 1 X&xxxx;= 1“
„028-007-00-4	xxxxxxxx xxxxxxxx; xxxxxxxxx xxxxxxxxx; [1] heazlewoodit [2]	234-829-6 [1] - [2]	12035-72-2 [1] 12035-71-1 [2]	Xxxx. 1 A Muta. 2 Xxxxx Xxx. 3 XXXX XX 1 Xxxx Xxxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X350x X341 X331 X372** X317 X400 X410	XXX08 XXX06 XXX09 Xxx	X350x X341 X331 X372** X317 X410		xxxxxxxxx: XXX&xxxx;= 0,92&xxxx;xx/x (xxxxx xxxx mlha)“
„029-002-00-X	oxid měďný	215-270-7	1317-39-1	Acute Xxx. 4 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X332 X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X302 X318 X410		xxxxxxxxx: XXX&xxxx;= 3,34 mg/l (xxxxx xxxx mlha) orální: XXX&xxxx;= 500&xxxx;xx/xx XX X&xxxx;= 100 X&xxxx;= 10“
„029-015-00-0	xxxxxxxxxxxx měďný	214-183-1	1111-67-7	Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410	XXX032	X&xxxx;= 10 M = 10“
„029-016-00-6	xxxx xxxxxxx	215-269-1	1317-38-0	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H400 H410	GHS09 Wng	H410		M = 100 X&xxxx;= 10“
„029-017-00-1	xxxxxxx-xxxxxxxxxxx xxxxxxxxx	215-572-9	1332-65-6	Xxxxx Xxx. 4 Xxxxx Tox. 3 Aquatic Xxxxx 1 Aquatic Xxxxxxx 1	X332 X301 X400 X410	XXX06 XXX09 Xxx	X332 X301 X410		xxxxxxxxx: ATE = 2,83 mg/l (xxxxx nebo xxxx) xxxxxx: XXX&xxxx;= 299 mg/kg TH M = 10 X&xxxx;= 10“
„029-018-00-7	xxxxxxxxxxxx-xxxxx tetraměďnatý; [1] xxxxxxxxxxxx-xxxxx tetraměďnatý hydrát [2]	215-582-3 [1] 215-582-3 [2]	1333-22-8 [1] 12527-76-3 [2]	Xxxxx Xxx. 4 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H302 H400 H410	GHS07 GHS09 Wng	H302 H410		orální: ATE = 500&xxxx;xx/xx TH M = 10 X&xxxx;= 10“
„029-019-01-X	xxxxxx xxxxxx (xxxxxxxx xxxxxxxxxxx xxxxxxxxx)	-	-	Xxxxx Xxx. 3 Xxxxx Tox. 4 Eye Xxxxx. 2 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	H331 H302 H319 H400 H410	GHS06 GHS09 Dgr	H331 H302 H319 H410		inhalační: XXX&xxxx;= 0,733&xxxx;xx/x (xxxxx xxxx mlha) orální: ATE = 500&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„029-020-00-8	xxxxxxxxx měďnatý – xxxxxxxx xxxxxxx (1:1)	235-113-6	12069-69-1	Acute Xxx. 4 Acute Xxx. 4 Xxx Xxxxx. 2 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X332 X302 X319 X400 X410	XXX07 XXX09 Xxx	X332 X302 X319 X410		xxxxxxxxx: XXX&xxxx;= 1,2&xxxx;xx/x (xxxxx xxxx xxxx) xxxxxx: XXX&xxxx;= 500&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„029-021-00-3	xxxxxxxx xxxxxxx	243-815-9	20427-59-2	Xxxxx Xxx. 2 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Aquatic Chronic 1	X330 X302 X318 X400 X410	XXX06 XXX05 XXX09 Xxx	X330 X302 X318 X410		xxxxxxxxx: XXX&xxxx;= 0,47 mg/l (xxxxx nebo mlha) orální: XXX&xxxx;= 500&xxxx;xx/xx XX X&xxxx;= 10 X&xxxx;= 10“
„029-022-00-9	xxxxxxxxxxx xxxxx; xxxxxxx xxxxxxxx síranu xxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx	-	8011-63-0	Xxxxx Xxx. 4 Xxx Xxx. 1 Aquatic Xxxxx 1 Aquatic Xxxxxxx 1	X332 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X318 X410		xxxxxxxxx: XXX&xxxx;= 1,97&xxxx;xx/x (xxxxx xxxx xxxx) X&xxxx;= 10 X&xxxx;= 1“
„029-023-00-4	xxxxx xxxxxxx, xxxxxxxxxxx	231-847-6	7758-99-8	Xxxxx Xxx. 4 Eye Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H302 H318 H400 H410	GHS07 GHS05 GHS09 Dgr	H302 H318 H410		orální: XXX&xxxx;= 481 mg/kg XX X&xxxx;= 10 X&xxxx;= 1“
„601-029-00-7	xxxxxxxx; xxxxxxx [1] (S)-p-mentha-1,8-dien; x-xxxxxxx [2] trans-1-methyl-4-(1-methylvinyl)cyklohexen; [3] (±)-1-xxxxxx-4-(1-xxxxxxxxxxx)xxxxxxxxxx [4]	205-341-0 [1] 227-815-6 [2] 229-977-3 [3] 231-732-0 [4]	138-86-3 [1] 5989-54-8 [2] 6876-12-6 [3] 7705-14-8 [4]	Xxxx. Xxx. 3 Skin Irrit. 2 Xxxx Sens. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X226 X315 X317 X400 X410	XXX02 XXX07 XXX09 Xxx	X226 X315 X317 X410			X“
„601-096-00-2	(X)-x-xxxxxx-1,8-xxxx; x-xxxxxxx	227-813-5	5989-27-5	Xxxx. Liq. 3 Skin Xxxxx. 2 Xxxx Xxxx. 1X Xxx. Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 3	X226 X315 X317 X304 X400 X412	XXX02 XXX07 XXX08 XXX09 Xxx	X226 X315 X317 X304 X410		X&xxxx;= 1“
„603-024-00-5	1,4-xxxxxx	204-661-8	123-91-1	Xxxx. Xxx. 2 Xxxx. 1B STOT XX 3 Xxx Xxxxx. 2	X225 X350 X335 X319	XXX02 XXX08 XXX07 Xxx	X225 X350 X335 X319	XXX019 XXX066		X“
„603-066-00-4	7-xxx-3-xxxxxxxxxxxxxxx[4.1.0]xxxxxx; 1,2-xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx 4-vinylcyklohexendiepoxid	203-437-7	106-87-6	Carc. 1B Muta. 2 Xxxx. 1X Xxxxx Xxx. 3 Xxxxx Tox. 4	H350 H341 H360F H331 H302	GHS08 GHS06 Dgr	H350 H341 H360F H331 H302		inhalační: XXX&xxxx;= 0,5&xxxx;xx/x (xxxxx xxxx mlha) oral: ATE = 1&xxxx;847 &xxxx;xx/xx TH“
„603-098-00-9	2-fenoxyethan-1-ol	204-589-7	122-99-6	Acute Xxx. 4 XXXX XX 3 Xxx Dam. 1	X302 X335 X318	XXX05 XXX07 Xxx	X302 X335 X318		xxxxxx: XXX&xxxx;= 1&xxxx;394 mg/kg XX“
„606-004-00-4	4-xxxxxxxxxxxx-2-xx; xxxxxxxx(xxxxxx)xxxxx	203-550-1	108-10-1	Xxxx. Xxx. 2 Xxxx. 2 Xxxxx Xxx. 4 XXXX XX 3 Xxx Xxxxx. 2	X225 X351 X332 X336 X319	XXX02 XXX07 XXX08 Xxx	X225 X351 X332 X336 X319	XXX066	xxxxxxxxx: XXX&xxxx;= 11&xxxx;xx/x (xxxx)“
„607-421-00-4	xxxxxxxxxxxx (XXX); α-xxxx-3-xxxxxxxxxxxx 3-(2,2-xxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxx xxx/xxxxx +/- 40/60	257-842-9	52315-07-8	Xxxxx Xxx. 4 Acute Xxx. 4 XXXX XX 3 XXXX XX 2 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X332 X302 X335 X373 (xxxxxxx xxxxxx) X400 X410	XXX07 XXX08 XXX09 Xxx	X332 X302 X335 X373 (xxxxxxx xxxxxx) X410		xxxxxx; XXX&xxxx;= 500&xxxx;xx/xx TH inhalační; XXX&xxxx;= 3,3&xxxx;xx/x (prach nebo xxxx) X&xxxx;= 100000 X&xxxx;= 100000“
„607-424-00-0	xxxxxxxxxxxxxxx (XXX); xxxxxx-(X)-α-(xxxxxxxxxxxx)-2-{[(X)-({1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx}xxxxx)xxx]xxxxxx}xxxxxx-1-xxxxxx	-	141517-21-7	Xxxx. Xxxx Sens. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X362 X317 X400 X410	XXX07 XXX09 Xxx	X362 X317 X410		X&xxxx;= 100 X&xxxx;= 10“
„607-434-00-5	xxxxxxxx-X (ISO) [1] x&xxxx;xxxx xxxx; (X)-2-(4-xxxxx-2-xxxxxxxxxxxx)xxxxxxxxx kyselina [1] x&xxxx;xxxx soli	240-539-0 [1]	16484-77-8 [1]	Xxxxx Xxx. 4 Xxx Dam. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X302 X318 X410		xxxxxx: XXX&xxxx;= 431&xxxx;xx/xx XX X&xxxx;= 10 M = 10“
„608-058-00-4	esfenvalerát (XXX); [(X)-(3-xxxxxxxxxxx)xxxxxxxxxx]-(X)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxxxxx	-	66230-04-4	Xxxxx Xxx. 3 Xxxxx Xxx. 3 STOT SE 1 XXXX XX 2 Skin Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	H331 H301 H370 (xxxxxxx xxxxxx) X373 X317 X400 X410	XXX06 XXX08 XXX09 Xxx	X331 X301 X370 (xxxxxxx xxxxxx) X373 X317 X410		xxxxxx; ATE = 88,5 mg/kg XX xxxxxxxxx; XXX&xxxx;= 0,53&xxxx;xx/x (xxxxx xxxx mlha) M = 10&xxxx;000 X&xxxx;= 10&xxxx;000 “
„612-067-00-9	3-(xxxxxxxxxxx)-3,5,5-xxxxxxxxxxxxxxxxxxx-1-xxxx	220-666-8	2855-13-2	Xxxxx Xxx. 4 Xxxx Corr. 1X Xxx Xxx. 1 Xxxx Xxxx. 1&xxxx;X	X302 X314 X318 X317	XXX05 XXX07 Xxx	X302 X314 X317		xxxxxx: XXX&xxxx;= 1&xxxx;030 &xxxx;xx/xx XX Xxxx Xxxx. 1&xxxx;X; X317: X&xxxx;≥&xxxx;0,001&xxxx;%“
„612-252-00-4	xxxxxxxxxxxx (XXX); (X)-1-(6-xxxxx-3-xxxxxxxxxxxxx)-X-xxxxxxxxxxxxxxxxx-2-xxxxxxxxxxx; (2X)-1-[(6-xxxxxxxxxxxx-3-xx) methyl]-N-nitroimidazolidin-2-imin	428-040-8	138261-41-3	Acute Xxx. 3 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	H301 H400 H410	GHS06 GHS09 Dgr	H301 H410		orální: XXX&xxxx;= 131&xxxx;xx/xx XX X&xxxx;= 100 X&xxxx;= 1 000 “
„613-048-00-8	xxxxxxxxxxx (XXX); methyl-N- (xxxxxxxxxxxx-2-xx)xxxxxxxx	234-232-0	10605-21-7	Xxxx. 1X Xxxx. 1X Xxxx Xxxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H340 H360FD H317 H400 H410	GHS07 GHS08 GHS09 Dgr	H340 H360FD H317 H410		M = 10 X&xxxx;= 10“
„613-102-00-0	xxxxxxxxxxx (XXX); (X,X)-4-(3-(4-xxxxxxxxxx)-3-(3,4-xxxxxxxxxxxxxx)xxxxxxxx)xxxxxxxx	404-200-2	110488-70-5	Xxxx. 1X Xxxxxxx Chronic 2	X360X X411	XXX08 XXX09 Xxx	X360X X411“
„613-111-00-X	1,2,4-xxxxxxx	206-022-9	288-88-0	Xxxx. 1X Xxxxx Xxx. 4 Xxx Xxxxx. 2	X360XX X302 X319	XXX08 XXX07 Xxx	X360XX X302 X319		xxxxxx: XXX&xxxx;= 1&xxxx;320 &xxxx;xx/xx XX“
„613-166-00-X	xxxxxxxxxxx (XXX); 7-xxxxx-4-(xxxx-2-xx-1-xx)-6-(3,4,5,6-xxxxxxxxxxxxxxxxxxx)-1,4-xxxxxxxxxx-3(2X)-xx	-	103361-09-7	Xxxx. 2 Aquatic Acute 1 Xxxxxxx Chronic 1	X361x X400 X410	XXX08 XXX09 Xxx	X361x X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 1&xxxx;000 “
„613-208-00-7	imazamox (XXX); (XX)-2-(4-xxxxxxxxx-4-xxxxxx-5-xxx-4,5-xxxxxxxxxxxxxxx-2-xx)-5-(xxxxxxxxxxxxx)xxxxxxxxxx kyselina	-	114311-32-9	Repr. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X361x X400 X410	XXX08 XXX09 Xxx	X361x X410		X&xxxx;= 10 M = 10“
„613-267-00-9	xxxxxxxxxxxx (XXX); X-xxxxx-{3-[(2-xxxxxxxxxxxx-5-xx)xxxxxx]-5-xxxxxx-1,3,5-xxxxxxxxxxx-4-xxxxxx}xxxx	428-650-4	153719-23-4	Xxxx. 2 Acute Tox. 4 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X361xx X302 X400 X410	XXX07 XXX08 XXX09 Xxx	X361xx X302 X410		xxxxxx: XXX&xxxx;= 780&xxxx;xx/xx XX X&xxxx;= 10 M = 10“
„613-282-00-0	xxxxxxxxxxxx (XXX); (1XX)-5-[(X)-4-xxxxxxxxxxxxxxx]-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx	-	138182-18-0	Xxxx. 2 XXXX XX 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H361f H373 H400 H410	GHS08 GHS09 Wng	H361f H373 H410		M = 1 X&xxxx;= 1“
„616-032-00-9	xxxxxxxxxxxx (XXX); X-(2,4-xxxxxxxxxxxx)-2-[3-(xxxxxxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx; 2′,4′-xxxxxxx-2-(α,α,α-xxxxxxxx-x-xxxxxxxx)xxxxxxxxxxxxx	-	83164-33-4	Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H400 H410	GHS09 Wng	H410		M = 10&xxxx;000 X&xxxx;= 1&xxxx;000 “
„616-106-00-0	xxxxxxxxxx (XXX); xxxxxx-X-(3-{[X-(3-(xxxxxxxxxxx)xxxxxxxxx]xxx}xxxxx)xxxxxxxx	237-199-0	13684-63-4	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 10 X&xxxx;= 10“
„616-113-00-9	xxxxxxxxxxx (ISO); ethyl-N-{3-[(N-fenylkarbamoyl)oxy]fenyl}karbamát	237-198-5	13684-56-5	Repr. 2 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X361x X400 X410	XXX08 XXX09 Xxx	X361x X410		X&xxxx;= 10 X&xxxx;= 10“

3)	xxxxxxx xxxxxxxxxxxx indexovému číslu 015-192-00-1 xx xxxxxxx.

Plné znění - 32021R0849

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2021/849

xx xxx 11.&xxxx;xxxxxx 2021,

xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxx xxxx část 3 xxxxxxx XX xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx a směsí

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Článek 2

Vstup x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxx

PŘÍLOHA

Plné znění - 32021R0849

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

NAŘÍZENÍ XXXXXX X&xxxx;XXXXXXXXX XXXXXXXXX (XX) 2021/849

xx xxx 11.&xxxx;xxxxxx 2021,

xxxxxx xx xxx účely xxxxxxxxxxxx xxxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxx xxxx část 3 xxxxxxx XX xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx a směsí

Xxxxxx&xxxx;1

Xxxxx xxxxxxxx (XX) x.&xxxx;1272/2008

Článek 2

Vstup x&xxxx;xxxxxxxx x&xxxx;xxxxxxxxxxxx

PŘÍLOHA

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.